Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-555-0 | CAS number: 15520-05-5
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Based on the available data base on Genamin 3920 relevant information exists to make a qualitative evaluation of the toxicokinetic profile of this compound. This is also in line with animal welfare considerations because additional animal tests can be avoided by such an evaluation.
The results of basic toxicity testing give no reason to anticipate unusual characteristics with regard to the toxicokinetics of Genamin 3920. The data indicate that there is little dermal absorption. On the other hand, Genamin 3920 is absorbed from the gastro-intestinal tract in toxicologically significant amounts. The structure as well as a computational model indicate a potential metabolism mainly via oxidative de-alkylation of the amine. Indications of a bio-accumulative potential as well as a metabolism towards genotoxic sub-structures do not exist. Excretion of systemically available Genamin 3920 and/or metabolites can be assumed.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Based on the available data base on Genamin 3920 relevant information exists to make a qualitative evaluation of the toxicokinetic profile of this compound. This is also in line with animal welfare considerations because additional animal tests can be avoided by such an evaluation.
The results of basic toxicity testing give no reason to anticipate unusual characteristics with regard to the toxicokinetics of Genamin 3920. The data indicate that there is little dermal absorption. On the other hand, Genamin 3920 is absorbed from the gastro-intestinal tract in toxicologically significant amounts. The structure as well as a computational model indicate a potential metabolism mainly via oxidative de-alkylation of the amine. Indications of a bio-accumulative potential as well as a metabolism towards genotoxic sub-structures do not exist. Excretion of systemically available Genamin 3920 and/or metabolites can be assumed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
